Skip to main content
Fig. 2 | Journal of Patient-Reported Outcomes

Fig. 2

From: Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial

Fig. 2

Inter-item Spearman correlation matrices for PKDD (a, b) and PKDIA (c, d) items at baseline. For the PKDD, the scoring values for Items 6 and 7 were inverted for consistency, to ensure that higher scores represented greater disease burden for all items. PKDD Pyruvate Kinase Deficiency Diary, PKDIA Pyruvate Kinase Deficiency Impact Assessment

Back to article page